IDC’s Bob Parker and Simon Ellis share groundbreaking research on how ongoing supply chain disruptions caused by COVID-19 are impacting the pharmaceutical industry. They also offer expert tips on how to adopt a holistic view of the end-to-end supply chain, achieve greater agility, and boost supply chain resiliency.
Key Takeaways
Gaining end-to-end supply chain visibility alone is not enough. You also need the ability to rapidly intervene and adapt to new conditions when supply chain disruptions are spotted.
Pharma supply chain companies should consider creating a decision environment that serves as a “process twin,” enabling them to quickly identify root causes and rectify adverse events in the supply chain.
Companies should stop deploying local or siloed solutions to fix problems. It’s time to do away with the “metaphorical Band-aids” and start thinking holistically about how to achieve supply chain resiliency.
The Agile-Supply Chain Credo is a set of guiding principles for transforming your supply chain and achieving real patient-centricity.
Podden och tillhörande omslagsbild på den här sidan tillhör
TraceLink. Innehållet i podden är skapat av TraceLink och inte av,
eller tillsammans med, Poddtoppen.
